New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463
about
Advances in Therapeutic Approaches to Extend Healthspan: a perspective from the 2nd Scripps Symposium on the Biology of Aging.Effects of 17-allylamino-17-demethoxygeldanamycin on the induction of apoptosis and cell cycle arrest in HCT-116 cells.Cellular Senescence: A Translational Perspective.The Clinical Potential of Senolytic Drugs.Identification of HSP90 inhibitors as a novel class of senolytics.p16(Ink4a) and senescence-associated β-galactosidase can be induced in macrophages as part of a reversible response to physiological stimuli.Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells.The Dual Role of Cellular Senescence in Developing Tumors and Their Response to Cancer Therapy.HIV as a Cause of Immune Activation and Immunosenescence.Mechanisms and Consequences of Oxidative Stress in Lung Disease: Therapeutic Implications for an Aging Populace.Cellular senescence in the aging and diseased kidney.Vascular Senescence in Cardiovascular and Metabolic Diseases.Association of chronic fatigue syndrome with premature telomere attrition.Inducers of Senescence, Toxic Compounds, and Senolytics: The Multiple Faces of Nrf2-Activating Phytochemicals in Cancer Adjuvant Therapy.Strategies targeting cellular senescence.Fibroblast senescence in the pathology of idiopathic pulmonary fibrosis.Blocking negative effects of senescence in human skin fibroblasts with a plant extract.Small extracellular vesicles and their miRNA cargo are anti-apoptotic members of the senescence-associated secretory phenotype.Effects of senolytic drugs on human mesenchymal stromal cells.Ionizing Radiation-Induced Cellular Senescence in Normal, Non-transformed Cells and the Involved DNA Damage Response: A Mini Review.Non-Cell Autonomous Effects of the Senescence-Associated Secretory Phenotype in Cancer Therapy.The mitomiR/Bcl-2 axis affects mitochondrial function and autophagic vacuole formation in senescent endothelial cellsTargeting senescence to delay progression of multiple sclerosisAgeing, Cellular Senescence and Neurodegenerative Disease
P2860
Q38430701-84A0FEEF-09B3-42BF-9A6D-D1A934B320A6Q38695460-8B663DCF-0970-45D7-BA99-1E044CB96A5EQ39246705-B42B9828-C010-4529-9E3F-CE5C6B44C378Q39312260-04ED88A0-942B-4C6F-8EC2-FB31FB79C23DQ41606906-7ACB08F1-8C8A-4386-A34A-03FEA92F3DDBQ41669905-72A2BFE1-8EAC-42F7-8E20-22644A63C825Q47110143-2CC43484-3FAC-4029-B83E-6EC9F5EF9F94Q47132545-328EF8A5-686F-41BD-852C-5F5FC653A599Q47151081-15A1A558-0C80-4438-A41C-650BBF44D031Q47652510-90839984-2734-4B79-8817-B84CF7A8B9BBQ48089331-6661C285-DDFB-4104-A52D-848883ACA337Q51761509-244D29A3-6AE5-429B-820D-6A496804A3D1Q51766849-2A8C46AA-707B-4313-BE81-E69DFDDCA4E7Q52331716-D39F3881-F504-42CF-9A6A-36AEDB1C1A5AQ52613750-F8E498DD-0E05-422A-8A77-AAF40757E69BQ52716546-846DFCFA-8F4A-4E3E-9654-904660A66785Q52804662-283C88C3-EFFF-4E2F-9A73-252F47142787Q54964433-F3A4EE71-07C8-40B7-B63E-CB11902E043FQ55030277-F1F9F92F-EFC1-4658-9913-9ABF572E957EQ55267324-AAE1E9AF-6031-4105-B66D-89D1A8B44621Q55312849-99C1C16F-BE97-46A5-912D-4F4E27216A21Q57806175-370A55C4-FF88-4825-A465-0FB62C66D517Q58721330-313399EA-ED87-4517-A14A-6436C128B5F0Q59133878-1342A2CD-2258-4955-8670-FEE435D5A4F3
P2860
New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
New agents that target senesce ...... ibitors, A1331852 and A1155463
@en
type
label
New agents that target senesce ...... ibitors, A1331852 and A1155463
@en
prefLabel
New agents that target senesce ...... ibitors, A1331852 and A1155463
@en
P2093
P2860
P356
P1433
P1476
New agents that target senesce ...... ibitors, A1331852 and A1155463
@en
P2093
Ewald J Doornebal
Heike Fuhrmann-Stroissnigg
James L Kirkland
Laura J Niedernhofer
Mark Wentworth
Nino Giorgadze
Paul D Robbins
Tamar Pirtskhalava
Tamara Tchkonia
P2860
P304
P356
10.18632/AGING.101202
P577
2017-03-08T00:00:00Z